World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
10844
World Ranking
17931
National Ranking
7339

Overview

R. Scott Turner is affiliated with Georgetown University in the United States and has contributed extensively to the fields of medicine and neuroscience. Their research predominantly centers on Alzheimer's disease and related dementias, with a significant focus on clinical and biomarker studies.

Their work is published mainly in the following venues:

  • Alzheimer's & Dementia
  • Frontiers in Neurology
  • Annals of Neurology
  • Frontiers in Aging Neuroscience
  • SSRN Electronic Journal

Turner's research covers a broad spectrum of subfields including physiology, psychiatry and mental health, cognitive neuroscience, neurology, and molecular biology.

The main topics addressed in their publications include:

  • Alzheimer's disease research and treatments
  • Dementia and cognitive impairment research
  • Functional brain connectivity studies
  • Neuroinflammation and neurodegeneration mechanisms
  • Chronic myeloid leukemia treatments
  • Health systems, economic evaluations, and quality of life
  • Health, environment, and cognitive aging

Some of their recent published papers are:

  • Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease, 2023, New England Journal of Medicine
  • Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease, 2022, Frontiers in Neurology
  • Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease, 2020, Annals of Neurology
  • Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias, 2020, Frontiers in Neurology
  • Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS), 2023, Alzheimer's & Dementia

Frequent collaborators in their research include:

  • Dustin B. Hammers
  • Alireza Atri
  • Ani Eloyan
  • Jeffrey L. Dage
  • Kelly Nudelman

Best Publications

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

    R. Scott Turner;Ronald G. Thomas;Suzanne Craft;Christopher H. van Dyck

  • FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

    Norman L. Foster;Judith L. Heidebrink;Christopher M. Clark;William J. Jagust

  • Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.

    Charbel Moussa;Michaeline Hebron;Xu Huang;Jaeil Ahn

  • In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease

    William C. Kreisl;Chul Hyoung Lyoo;Meghan McGwier;Joseph Snow

  • Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents.

    B. C. Wise;D. B. Glass;C. H. J. Chou;R. L. Raynor

  • The X11α Protein Slows Cellular Amyloid Precursor Protein Processing and Reduces Aβ40 and Aβ42 Secretion

    Jean-Paul Borg;Yunning Yang;Mylène De Taddéo-Borg;Ben Margolis

  • ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo

    Sonya B. Dumanis;Joseph A. Tesoriero;Lenard W. Babus;Madeline T. Nguyen

  • Resveratrol for Alzheimer's disease

    Christine Sawda;Charbel Moussa;R. Scott Turner

  • IDENTIFICATION OF AN EVOLUTIONARILY CONSERVED HETEROTRIMERIC PROTEIN COMPLEX INVOLVED IN PROTEIN TARGETING

    Jean Paul Borg;Samuel W. Straight;Susan M. Kaech;Mylène De Taddéo-Borg

  • The Chaperone BiP/GRP78 Binds to Amyloid Precursor Protein and Decreases Aβ40 and Aβ42 Secretion

    Yunning Yang;R. Scott Turner;James R. Gaut

  • Amyloids and Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation

    R. Scott Turner;Nobuhiro Suzuki;Abraham S.C. Chyung;Steven G. Younkin

  • Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?

    Gwendalyn D. King;R. Scott Turner;R. Scott Turner

  • Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?

    Jeanne S. Mandelblatt;Robert A. Stern;Gheorghe Luta;Meghan McGuckin

  • X11 Interaction with β-Amyloid Precursor Protein Modulates Its Cellular Stabilization and Reduces Amyloid β-Protein Secretion

    Magdalena Sastre;R. Scott Turner;Efrat Levy

  • Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease.

    Kevin A. Corcoran;Ye Lu;R. Scott Turner;R. Scott Turner;Stephen Maren

  • Phospholipid-sensitive Ca2+-dependent protein kinase: a major protein phosphorylation system

    J.F. Kuo;Randall C. Schatzman;R.Scott Turner;Gonzalo J. Mazzei

  • (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease.

    William C. Kreisl;Chul Hyoung Lyoo;Jeih San Liow;Monica Wei

  • Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.

    Sang Ho Choi;Saba Aid;Luca Caracciolo;S. Sakura Minami

  • Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.

    You Me Sung;Taehee Lee;Hyejin Yoon;Amanda Marie DiBattista

Frequent Co-Authors

J.F. Kuo
J.F. Kuo Emory University
Christopher M. Clark
Christopher M. Clark University of Pennsylvania
Steven E. Arnold
Steven E. Arnold Harvard University
G. William Rebeck
G. William Rebeck Georgetown University Medical Center
Norman L. Foster
Norman L. Foster University of Utah
Robert A. Koeppe
Robert A. Koeppe University of Michigan–Ann Arbor
William J. Jagust
William J. Jagust University of California, Berkeley
Robert B. Innis
Robert B. Innis National Institutes of Health
Charles DeCarli
Charles DeCarli University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens up a range of exciting career options and online learning opportunities. Many students explore the dynamic field of health information management and medical coding, where the demand for skilled professionals is rising. If you’re interested in this path, it’s useful to explore the medical coding salary to understand earning potential and how it compares with similar roles.

The medical billing and coding outlook also highlights the pros and cons of this career, helping you decide if it’s the right fit. Those seeking flexible learning can consider health information management online programs to build expertise while balancing other commitments.

Beyond coding and information management, many Biology and Biochemistry grads pursue work in nutrition. There are accessible options to further your studies, such as online degrees in nutrition that can boost your credentials and career prospects. Each of these pathways offers diverse options for specialization in the digital age.

Best Scientists Citing R. Scott Turner

Trending Scientists

Recently Published Articles